| Claim | Status |
|---|---|
| EPS consensus $3.81/ADR | Confirmed |
| Revenue ~$40B | Confirmed (guided $39.0–$40.2B) |
| Gross margin approaching 70% | Not confirmed — guided range tops at 67.5% |
| FY2026 revenue raised to >30% growth | Confirmed |
| 2026 capex $56B | Confirmed ($52–56B range, high end) |
| 2027 capex $73B | Partially — BofA published $75B, not $73B |
| 44% YTD stock gain | Not directly sourced but consistent with reported rally |
| Barclays PT $625 | Confirmed |
| Citi PT T$3,800 | Not found in search results |
| GF Securities PT NT$2,900 | Not found — published target is NT$2,808 |
| 2nm volume production by H2 2025 | Confirmed |
| Five 2nm fabs ramping in 2026 | Confirmed |
| Claim | Status |
|---|---|
| EPS consensus $3.81/ADR | Confirmed |
| Revenue ~$40B | Confirmed (guided $39.0–$40.2B) |
| Gross margin approaching 70% | Not confirmed — guided range tops at 67.5% |
| FY2026 revenue raised to >30% growth | Confirmed |
| 2026 capex $56B | Confirmed ($52–56B range, high end) |
| 2027 capex $73B | Partially — BofA published $75B, not $73B |
| 44% YTD stock gain | Not directly sourced but consistent with reported rally |
| Barclays PT $625 | Confirmed |
| Citi PT T$3,800 | Not found in search results |
| GF Securities PT NT$2,900 | Not found — published target is NT$2,808 |
| 2nm volume production by H2 2025 | Confirmed |
| Five 2nm fabs ramping in 2026 | Confirmed |